0

Journal Articles

in Diabetes Mellitus Treatment
 81-100 of 102 Articles
Clinical Investigation |  May 15, 2002 FREE
Effects of Moderate Alcohol Intake on Fasting Insulin and Glucose Concentrations and Insulin Sensitivity in Postmenopausal Women:  A Randomized Controlled Trial
Michael J. Davies, PhD; David J. Baer, PhD; Joseph T. Judd, PhD; et al.
JAMA. 2002;287(19):2559-2562. doi:10.1001/jama.287.19.2559.
Original Contribution |  May 15, 2002 FREE
Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes
The CDC Diabetes Cost-effectiveness Group
JAMA. 2002;287(19):2542-2551. doi:10.1001/jama.287.19.2542.
Clinical Investigation |  March 20, 2002 FREE
Relationship Between Insulin Resistance and an Endogenous Nitric Oxide Synthase Inhibitor
Markus C. Stühlinger, MD; Fahim Abbasi, MD; James W. Chu, MD; et al.
JAMA. 2002;287(11):1420-1426. doi:10.1001/jama.287.11.1420.
Scientific Review and Clinical Applications |  January 16, 2002 FREE
Oral Antihyperglycemic Therapy for Type 2 Diabetes:  Scientific Review
Silvio E. Inzucchi, MD
JAMA. 2002;287(3):360-372. doi:10.1001/jama.287.3.360.
Scientific Review and Clinical Applications |  January 16, 2002 FREE
Oral Antihyperglycemic Therapy for Type 2 Diabetes:  Clinical Applications
Eric S. Holmboe, MD
JAMA. 2002;287(3):373-376. doi:10.1001/jama.287.3.373.
Review |  September 12, 2001 FREE
Effects of Exercise on Glycemic Control and Body Mass in Type 2 Diabetes Mellitus:  A Meta-analysis of Controlled Clinical Trials
Normand G. Boulé, MA; Elizabeth Haddad, MD; Glen P. Kenny, PhD; et al.
JAMA. 2001;286(10):1218-1227. doi:10.1001/jama.286.10.1218.
Brief Report |  August 15, 2001 FREE
Liver Enzyme Monitoring in Patients Treated With Troglitazone
David J. Graham, MD, MPH; Carol R. Drinkard, MPH, PhD; Deborah Shatin, PhD; et al.
JAMA. 2001;286(7):831-833. doi:10.1001/jama.286.7.831.
The World in Medicine |  February 14, 2001
New Insulin Regulation Finding
JAMA. 2001;285(6):725. doi:10-1001/pubs.JAMA-ISSN-0098-7484-285-6-jwm10001.
Original Contribution |  January 10, 2001 FREE
Effect of Improved Glycemic Control on Health Care Costs and Utilization
Edward H. Wagner, MD, MPH; Nirmala Sandhu, MPH; Katherine M. Newton, PhD; et al.
JAMA. 2001;285(2):182-189. doi:10.1001/jama.285.2.182.
Original Contribution |  October 11, 2000 FREE
Differences in Prognostic Factors and Outcomes Between Women and Men Undergoing Coronary Artery Stenting
Julinda Mehilli, MD; Adnan Kastrati, MD; Josef Dirschinger, MD; et al.
JAMA. 2000;284(14):1799-1805. doi:10.1001/jama.284.14.1799.
Preliminary Communication |  July 26, 2000 FREE
Metformin in the Treatment of HIV Lipodystrophy Syndrome:  A Randomized Controlled Trial
Colleen Hadigan, MD; Colleen Corcoran, NP; Nesli Basgoz, MD; et al.
JAMA. 2000;284(4):472-477. doi:10.1001/jama.284.4.472.
From the Food and Drug Administration |  May 03, 2000
Withdrawal of Troglitazone and Cisapride
JAMA. 2000;283(17):2228. doi:10.1001/jama.283.17.2228.
Original Contribution |  April 05, 2000 FREE
Effect of Metformin and Rosiglitazone Combination Therapy in Patients With Type 2 Diabetes Mellitus:  A Randomized Controlled Trial
Vivian Fonseca, MD; Julio Rosenstock, MD; Rita Patwardhan, PhD; et al.
JAMA. 2000;283(13):1695-1702. doi:10.1001/jama.283.13.1695.
Original Contribution |  January 12, 2000 FREE
Hyperinsulinemia, Hyperglycemia, and Impaired Hemostasis:  The Framingham Offspring Study
James B. Meigs, MD, MPH; Murray A. Mittleman, MDCM, DrPH; David M. Nathan, MD; et al.
JAMA. 2000;283(2):221-228. doi:10.1001/jama.283.2.221.
Original Contribution |  November 17, 1999 FREE
Noninvasive Glucose Monitoring:  Comprehensive Clinical Results
Janet A. Tamada, PhD; Satish Garg, MD; Lois Jovanovic, MD; et al.
JAMA. 1999;282(19):1839-1844. doi:10.1001/jama.282.19.1839.
From the Food and Drug Administration |  September 08, 1999
New Type 2 Diabetes Drugs
JAMA. 1999;282(10):932. doi:10.1001/jama.282.10.932.
Original Contribution |  June 09, 1999 FREE
The Unreliability of Individual Physician "Report Cards" for Assessing the Costs and Quality of Care of a Chronic Disease
Timothy P. Hofer, MD, MS; Rodney A. Hayward, MD; Sheldon Greenfield, MD; et al.
JAMA. 1999;281(22):2098-2105. doi:10.1001/jama.281.22.2098.
Original Contribution |  June 02, 1999 FREE
Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes Mellitus:  Progressive Requirement for Multiple Therapies (UKPDS 49)
Robert C. Turner, FRCP; Carole A. Cull, PhD; Valeria Frighi, MD; et al.
JAMA. 1999;281(21):2005-2012. doi:10.1001/jama.281.21.2005.
Medical News and Perspectives |  January 13, 1999
New Method to Repair Faulty Genes Stirs Interest in Chimeraplasty TechniqueSwitch to Human Insulin Worries Some DiabeticsA Thought for Your PenniesNew Method to Repair Faulty Genes Stirs Interest in Chimeraplasty TechniqueSwitch to Human Insulin Worries Some DiabeticsA Thought for Your Pennies
JAMA. 1999;281(2):119-121. doi:10.1001/jama.281.2.119.
Original Contribution |  November 04, 1998 FREE
Health Economic Benefits and Quality of Life During Improved Glycemic Control in Patients With Type 2 Diabetes Mellitus:  A Randomized, Controlled, Double-Blind Trial
Marcia A. Testa, MPH, PhD; Donald C. Simonson, MD
JAMA. 1998;280(17):1490-1496. doi:10.1001/jama.280.17.1490.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  |  May 13, 2013
Adulterated Sexual Enhancement Supplements:  More Than Mojo
Pieter A. Cohen, MD; Bastiaan J. Venhuis, PhD
JAMA Internal Medicine
Editorial  |  April 22, 2013
Trust in the Medical Literature—and Viewpoints in JAMA Internal Medicine
Robert Steinbrook, MD; Rita F. Redberg, MD, MSc
JAMA Internal Medicine
Original Investigation  |  February 25, 2013
Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus:  A Population-Based Matched Case-Control Study
Sonal Singh, MD, MPH; Hsien-Yen Chang, PhD; Thomas M. Richards, MS; et al.
JAMA Internal Medicine
Invited Commentary  |  Mar 11, 2013
From “Pull” to “Push”: A Transformation in Medicine:  Comment on “Participatory Surveillance of Hypoglycemia and Harms in an Online Social Network”
Aaron Barak Neinstein, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems